Uterine Organoid Platform

About Opal Therapeutics

Opal Therapeutics is a private, pre-clinical stage biotech company pioneering a 'uterus in a dish' platform using patient-derived uterine organoids. The company aims to address the historical inadequacy of traditional animal models in women's health R&D by providing scalable, biologically relevant human tissue models for drug testing and development. Its business model appears to combine R&D services with internal therapeutic development, targeting a large and underserved market in gynecological diseases. The company is active in the startup ecosystem, participating in accelerator programs and public engagement to advance the field.

Therapeutic Areas